Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Feline Urine Protein Clearance Analysis: Testing Methods, Standards, and Clinical Applications

Feline urine protein clearance analysis is a quantitative diagnostic approach that evaluates how effectively a cat's kidneys retain or excrete proteins, providing critical insight into glomerular and tubular function. By measuring the urine protein-to-creatinine ratio (UPC) and related biomarkers, this analysis enables early detection of chronic kidney disease, glomerulonephritis, and other protein-losing nephropathies before irreversible renal damage develops. This article explains the sample requirements, tested parameters, analytical methods, quality standards, and clinical applications of professional feline urine protein clearance testing performed by accredited third-party laboratories.

Technical Overview

Feline urine protein clearance analysis quantifies the rate at which proteins pass from the bloodstream into urine, offering a sensitive indicator of renal filtration barrier integrity and tubular reabsorptive capacity. In healthy cats, the glomerular capillary wall, composed of fenestrated endothelium, the basement membrane, and podocyte slit diaphragms, provides both size-selective and charge-selective filtration. Large proteins such as albumin (approximately 69 kDa) are largely retained in circulation, while low-molecular-weight proteins that are freely filtered are reabsorbed and degraded by proximal tubular epithelial cells. Consequently, physiologic daily urinary protein loss is minimal.

When this system fails, proteinuria develops and can be classified into several pathophysiologic categories:

  • Glomerular proteinuria: caused by glomerulonephritis, amyloidosis, or hypertension-related glomerular injury; typically albumin-dominant and often associated with markedly elevated UPC values.
  • Tubular proteinuria: results from impaired reabsorption of low-molecular-weight proteins due to tubular interstitial disease or toxic injury.
  • Pre-renal (overflow) proteinuria: caused by excessive production of small proteins, such as paraproteins in plasma cell dyscrasias, that overwhelm reabsorptive capacity.
  • Post-renal proteinuria: arises from hemorrhage or inflammation in the lower urinary or genital tract.
  • Functional (transient) proteinuria: linked to stress, fever, or excitement and usually resolves without treatment.

Because timed 24-hour urine collection is impractical in cats, the urine protein-to-creatinine ratio (UPC) measured on a single urine sample is the clinically validated surrogate for daily protein excretion. Formal clearance studies, where required, are calculated as clearance (mL/min/kg) = (urine protein concentration × urine flow rate) ÷ plasma protein concentration, or expressed as fractional excretion using simultaneously measured urine and plasma creatinine. Testing is performed under ISO 15189 medical laboratory requirements or ISO/IEC 17025 general competence requirements to ensure analytical validity and traceable results.

Testing Samples

Urine Samples

A volume of 1 to 5 mL of fresh urine is required. Ultrasound-guided cystocentesis is the preferred collection method because it yields a sterile sample free of lower tract contamination. Free-catch samples are acceptable for initial screening but may introduce post-renal protein, blood, or cellular debris that complicates interpretation. Samples should be analyzed within 30 to 60 minutes of collection or refrigerated at 2–8 °C for up to 24 hours; repeated freeze-thaw cycles should be avoided. Urine must be centrifuged before quantitative protein assay to remove cells and casts, and any gross hematuria must be documented.

Blood (Serum or Plasma) Samples

A paired blood sample of 0.5 to 1 mL, collected on the same day as the urine sample, is used to measure serum creatinine, albumin, total protein, and SDMA. These values support clearance calculations, chronic kidney disease staging, and differentiation of renal from pre-renal causes of protein loss.

Timed or Serial Urine Collections

In research settings or specialized nephrology investigations, timed urine collections using metabolic cages or intermittent catheterization may be performed to derive direct clearance values with endogenous or exogenous markers such as inulin or iohexol.

Testing Items

A comprehensive feline urine protein clearance panel typically includes the following quantitative and semi-quantitative parameters:

  • Urine protein-to-creatinine ratio (UPC), the core quantitative index of renal protein loss
  • Quantitative urine albumin determination, including microalbuminuria detection
  • Urine total protein concentration
  • Urine creatinine concentration
  • Urine protein electrophoresis pattern to distinguish glomerular, tubular, mixed, and overflow proteinuria
  • Serum creatinine and symmetric dimethylarginine (SDMA) for renal function staging
  • Glomerular filtration rate (GFR) estimation by plasma iohexol or inulin clearance where indicated
  • Complete urinalysis, including urine specific gravity, dipstick chemistry, and sediment microscopy, to exclude active inflammation and hemorrhage

Testing Methods

Urine Protein-to-Creatinine Ratio (UPC)

Urine total protein is quantified by pyrogallol red-molybdate colorimetry or benzethonium chloride turbidimetry, while urine creatinine is measured by the kinetic Jaffe method or an enzymatic creatininase assay. The UPC is calculated as urine protein concentration (mg/dL) divided by urine creatinine concentration (mg/dL). Under internationally recognized veterinary renal staging guidelines, a UPC below 0.2 on an inactive sediment is classified as non-proteinuric, 0.2 to 0.4 as borderline, and above 0.4 as proteinuric in cats, a threshold set lower than in dogs owing to species-specific physiology. Persistent proteinuria should be confirmed by at least two to three analyses performed within two to four weeks.

Species-Specific Albumin Immunoassay

Quantitative albumin measurement employs feline-specific ELISA or immunoturbidimetric methods using antibodies validated against feline albumin. Species-specific assay design is essential because generic protein assays calibrated with bovine or heterologous albumin standards may underestimate albuminuria. Microalbuminuria testing detects albumin losses below the detection threshold of dipsticks and standard UPC assays, serving as an early marker of glomerular injury.

Urine Protein Electrophoresis

Agarose gel or capillary electrophoresis separates urinary proteins by molecular size and charge. An albumin-dominant pattern indicates glomerular disease, a low-molecular-weight globulin pattern supports tubular dysfunction, and monoclonal spikes suggest overflow proteinuria requiring further investigation for Bence-Jones proteins.

Glomerular Filtration Rate (GFR) Testing

When functional assessment is required alongside protein clearance, plasma iohexol clearance using single-compartment or limited-sampling pharmacokinetic models, or classical inulin renal clearance, provides the reference measurement of filtration function.

Quality Assurance and Standards Compliance

Accredited third-party laboratories operating under ISO 15189 or ISO/IEC 17025 apply instrument calibration with species-appropriate reference materials, internal quality control at multiple decision levels, participation in interlaboratory proficiency testing, and method validation covering precision, accuracy, reference intervals, and measurement uncertainty.

Applications

Feline urine protein clearance analysis supports a wide range of clinical, breeding, and research objectives:

  • Early detection of glomerular disease before the onset of azotemia, enabling timely intervention in chronic kidney disease
  • Substaging of chronic kidney disease according to proteinuria status, which directly informs prognosis and treatment intensity
  • Monitoring of protein-losing nephropathy and objective assessment of therapeutic response to renin-angiotensin system inhibitors, such as telmisartan or ACE inhibitors, and protein-restricted renal diets
  • Evaluation of end-organ kidney damage in systemic hypertension, diabetes mellitus, and hyperthyroidism
  • Investigation of immune-complex glomerulonephritis in cats with retroviral or chronic infectious and inflammatory disease
  • Screening of predisposed breeds, such as Abyssinian and Siamese cats, for familial renal amyloidosis
  • Geriatric wellness programs and pre-anesthetic or pre-breeding renal risk assessment
  • Preclinical research, nephrotoxicity evaluation, and renal safety studies in veterinary pharmaceutical development

FAQ

What UPC value is considered abnormal in cats?

A UPC persistently above 0.4 obtained from urine with an inactive sediment is classified as proteinuric. Values between 0.2 and 0.4 are borderline and should be rechecked on two to three separate samples within two to four weeks before a diagnosis is established.

How is the urine sample collected?

Ultrasound-guided cystocentesis is the recommended technique because it produces a sterile sample without contamination from the lower urinary tract. Free-catch samples may be used for screening but require cautious interpretation.

Can a dipstick test replace the UPC measurement?

No. Dipstick assays are semi-quantitative, detect mainly albumin, and are strongly influenced by urine concentration. Any clinically significant dipstick positivity should be confirmed with a quantitative UPC measured in a laboratory.

Do blood or inflammation in the urine affect the results?

Yes. Hemorrhage, inflammation, or infection anywhere in the urogenital tract can cause post-renal proteinuria and falsely elevate the UPC. When the urine sediment is active, the underlying condition should be treated and the UPC repeated before renal proteinuria is diagnosed.

How often should protein clearance be monitored?

Diagnosis generally requires two to three confirmatory samples within two to four weeks. Cats with stable chronic kidney disease are typically monitored every three months, while patients starting or adjusting anti-proteinuric therapy are usually rechecked two to four weeks after the change.

Are some cats more prone to abnormal protein clearance?

Yes. Senior cats have an elevated risk of chronic kidney disease, and breeds such as the Abyssinian and Siamese are predisposed to familial renal amyloidosis. Cats with systemic hypertension, diabetes mellitus, or retroviral infections also warrant closer surveillance of urinary protein loss.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing